Research Topics
Genomes and GenesSpecies | Z K WszolekSummaryAffiliation: Mayo Clinic Country: USA Publications
| Collaborators
|
Detail Information
Publications
Autosomal dominant cerebellar ataxia type III: a review of the phenotypic and genotypic characteristicsShinsuke Fujioka
Department of Neurology at Mayo Clinic, 4500 San Pablo Road Cannaday Bldg 2 E, Jacksonville, FL 32224, USA
Orphanet J Rare Dis 8:14. 2013..There is no cure for ADCA Type III, but a number of recent studies have highlighted novel therapies, which bring hope for future curative treatments...
MRI characteristics and scoring in HDLS due to CSF1R gene mutationsChristina Sundal
Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
Neurology 79:566-74. 2012..To describe the brain MRI characteristics of hereditary diffuse leukoencephalopathy with spheroids (HDLS) with known mutations in the colony-stimulating factor 1 receptor gene (CSF1R) on chromosome 5...
Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implicationsMariet Allen
Mayo Clinic Florida, Department of Neuroscience, Jacksonville, FL, USA
Mol Neurodegener 7:13. 2012..4,617 controls) and PD (678 PDs vs. 712 controls) for association with disease risk (case-controls), age-at-diagnosis (cases) and brain gene expression levels (autopsied subjects)...
Polymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control studyLisa F Potts
Department of Anatomical Sciences and Neurobiology, University of Louisville, KY, USA
BMC Med Genet 13:16. 2012....
Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristicsNathaniel Robb Whaley
Tri State Mountain Neurology, 105 Woodlawn Dr, Johnson City, TN 27604, USA
Orphanet J Rare Dis 6:33. 2011..Care is therefore supportive. Occupational and physical therapy for gait dysfunction and speech therapy for dysarthria is essential. Prognosis is variable depending on the type of ADCA and even among kindreds...
High-throughput mutational analysis of TOR1A in primary dystoniaJianfeng Xiao
Department of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA
BMC Med Genet 10:24. 2009..The aim of this study was to identify TOR1A Exon 5 mutations in a large cohort of subjects with mainly non-generalized primary dystonia...
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)Zbigniew K Wszolek
Department of Neurology, Mayo Clinic, FL, USA
Orphanet J Rare Dis 1:30. 2006..The prognosis and rate of the disease's progression vary considerably among individual patients and genetic kindreds, ranging from life expectancies of several months to several years, and, in exceptional cases, as long as two decades...
Frontotemporal dementia and parkinsonism linked to chromosome 17Zbigniew K Wszołek
Department of Neurology, Mayo Clinic, 4500 San Pablo Rd, Jacksonsville, FL 32224, USA
Folia Neuropathol 43:258-70. 2005..The definitive diagnosis of FTDP-17 requires a set of clinical and pathological features combined with a molecular genetic analysis. Currently, there is no known effective treatment for FTDP-17...
A family with Parkinsonism, essential tremor, restless legs syndrome, and depressionA Puschmann
Department of Neurology, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Neurology 76:1623-30. 2011..Previous epidemiologic and genetic studies have suggested a link between Parkinson disease (PD), essential tremor (ET), and restless legs syndrome (RLS)...
Autosomal dominant dystonia-plus with cerebral calcificationsZ K Wszolek
Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Neurology 67:620-5. 2006..To report genealogic, clinical, imaging, neuropathologic, and genetic data from a Canadian kindred with dystonia and brain calcinosis originally described in 1985...
Association of the MAPT locus with Parkinson's diseaseC Wider
Department of Neuroscience, Mayo Clinic, Molecular Genetics Laboratory and Core, Morris K Udall Parkinsons Disease Research Center of Excellence, Jacksonville, FL 32224, USA
Eur J Neurol 17:483-6. 2010..Whilst an association between the tau gene (MAPT)-containing H1 haplotype and supranuclear gaze palsy (PSP) has long been recognized, the effect of H1 on risk for Parkinson's disease (PD) has remained more contentious...
Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutationsJ L Whitwell
Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
Neurology 73:1058-65. 2009..To use a case-control study to assess and compare patterns of gray matter loss across groups of subjects with different mutations in the microtubule-associated protein tau (MAPT) gene...
Characterization of DCTN1 genetic variability in neurodegenerationC Vilariño-Güell
Molecular Genetics Laboratory and Core, Morris K Udall Parkinson s Disease Research Center of Excellence, Mayo Clinic, Department of Neuroscience, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Neurology 72:2024-8. 2009....
Trajectories of brain and hippocampal atrophy in FTD with mutations in MAPT or GRNJ L Whitwell
Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
Neurology 77:393-8. 2011..To use multiple serial MRI to assess rates and trajectories of brain and hippocampal atrophy in subjects with frontotemporal dementia (FTD) with progranulin (GRN) or microtubule-associated protein tau (MAPT) gene mutations...
MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathologyK Kantarci
Departmentsof Radiology, Mayo Clinic, Rochester, MN 55905, USA
Neurology 75:771-8. 2010..To determine the proton magnetic resonance spectroscopy ((1)H MRS) changes in carriers of microtubule-associated protein (MAPT) mutations in a case-control study...
Autosomal dominant parkinsonism associated with variable synuclein and tau pathologyZ K Wszolek
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Neurology 62:1619-22. 2004..Genetic studies suggested linkage to the PARK8 locus on chromosome 12...
Calbindin-1 association and Parkinson's diseaseA I Soto-Ortolaza
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA
Eur J Neurol 17:208-11. 2010..Recently, an association was reported between the calcium buffer, calbindin (rs1805874) and risk of PD in a Japanese patient-control series...
Death-associated protein kinase 1 variation and Parkinson's diseaseJ C Dachsel
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
Eur J Neurol 18:1090-3. 2011..The Lrrk2 protein is a member of the ROCO family, which also includes Lrrk1 and Dapk1. Functional genetic variants of the DAPK1 gene (rs4877365 and rs4878104) have been previously associated with Alzheimer's disease...
SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction studyC Wider
Division of Neurogenetics, Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
Eur J Neurol 18:876-81. 2011..In the current study, we attempt to validate previously published findings, evaluating gene-gene interactions between SNCA, MAPT, and GSK3B in association with PD...
Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genesA B West
Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, Florida, FL 32224, USA
Eur J Hum Genet 9:659-66. 2001..5 Mb. Analysis of 14 genes within the region did not reveal any potentially pathogenic mutations segregating with the disease, implying that none of these genes are likely candidates for PARK3...
Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRNJ L Whitwell
Department of Radiology Research, Mayo Clinic, Rochester, MN 55905, USA
Neurology 72:813-20. 2009..To compare patterns of gray matter loss in subjects with mutations in the progranulin (PGRN) gene to subjects with mutations in the microtubule-associated protein tau (MAPT) gene...
Pallidonigral TDP-43 pathology in Perry syndromeChristian Wider
Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
Parkinsonism Relat Disord 15:281-6. 2009..This study reports clinical, genetic and neuropathologic investigations of Perry syndrome...
GRN 3'UTR+78 C>T is not associated with risk for Parkinson's diseaseB Jasinska-Myga
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
Eur J Neurol 16:909-11. 2009..rs5848 is located within a micro-RNA binding site and affects the expression of GRN...
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriersN Finch
Department of Neuroscience, Mayo Clinic College of Medicine, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Neurology 76:467-74. 2011....
Gender and the Parkinson's disease phenotypeYasuhiko Baba
Dept. of Neurology, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA
J Neurol 252:1201-5. 2005..However, gender may be an important factor related to the expression of PD features during the symptomatic disease course...
GCH1 in early-onset Parkinson's diseaseStephanie A Cobb
Division of Neurogenetics, Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA
Mov Disord 24:2070-5. 2009..This study does not support a significant role for genetic variation at the GCH1 locus in EOPD. However, our results further highlight the relevance of PRKN screening in familial EOPD...
Susceptibility genes for restless legs syndrome are not associated with Parkinson diseaseC Vilariño-Güell
Department of Neuroscience, Division of Neurogenetics, Mayo Clinic, Jacksonville, FL 32224, USA
Neurology 71:222-3. 2008
Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTDJ L Whitwell
Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA
Neurology 77:866-74. 2011....
Recent advances in the understanding of tau protein and movement disordersZ Arvanitakis
Mayo Clinic, Jacksonville, Florida 32224, USA
Curr Opin Neurol 14:491-7. 2001..Despite recent advances in the understanding of the tauopathies, there are still no curative therapies available. It is hoped that studies in transgenic tau animal models will lead to the development of successful treatments...
Thalamic deep brain stimulation for essential tremor: recommendations for long-term outcome analysisJ D Putzke
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Can J Neurol Sci 31:333-42. 2004..CONCLUSION: Thalamic DBS is generally a well-tolerated and effective treatment for ET. Methodological and analytical recommendations are provided for the evaluation of long-term outcome...
Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseK Haugarvoll
Department of Neurology, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
Neurology 70:1456-60. 2008..Several dominantly inherited pathogenic substitutions have been identified in different domains of the Lrrk2 protein. Herein, we characterize the clinical and genetic features associated with Lrrk2 p.R1441C...
Phenotypic commonalities in familial and sporadic Parkinson diseaseYasuhiko Baba
Department of Neurology and Section of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Arch Neurol 63:579-83. 2006..Phenotypic similarity among familial and sporadic PD indicates that a similar topographic distribution of the nigrostriatal lesion exists in patients with either form of PD regardless of apparent genetic influence...
The effect of tau genotype on clinical features in FTDP-17Yasuhiko Baba
Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 11:205-8. 2005..7; 95% confidence interval, 1.4-98.7; P=0.008). Our results suggest that tau genotype does not influence the disease course. However, it may predispose to a specific clinical sign in the early stage of FTDP-17...
Phactr2 and Parkinson's diseaseChristian Wider
Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
Neurosci Lett 453:9-11. 2009..15, P=0.27). When combining all four series the observed trend was statistically significant (OR: 1.30, P<0.001). This study shows that reappraisal of publicly available results of GWAS may help nominate new risk factors for PD...
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populationsJennifer Kachergus
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
Am J Hum Genet 76:672-80. 2005..Our work highlights the fact that a proportion of clinically typical, late-onset PD cases have a genetic basis...
Bilateral thalamic deep brain stimulation: midline tremor controlJ D Putzke
Department of Neurology, Mayo Clinic Jacksonville, FL 32224, USA
J Neurol Neurosurg Psychiatry 76:684-90. 2005..CONCLUSIONS: Unilateral thalamic stimulation significantly improves midline tremor, and subsequent bilateral thalamic stimulation offers an additional incremental improvement in midline tremor control...
Essential tremor: predictors of disease progression in a clinical cohortJ D Putzke
Department of Neurology, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA
J Neurol Neurosurg Psychiatry 77:1235-7. 2006..05). CONCLUSION: Essential tremor is a slow, progressive disease. The rate of disease progression and the factors associated with disease progression may vary throughout the disease course...
Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutationY Baba
Department of Neurology, Mayo Clinic, Jacksonville, Florida 32224, USA
J Neural Transm 114:947-50. 2007..Thus, the tau haplotype carrying the mutation and the tau genotype may be related to the clinical phenotype throughout the disease course...
Novel THAP1 sequence variants in primary dystoniaJ Xiao
Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA
Neurology 74:229-38. 2010..Subsequent screening efforts in familial, mainly early-onset, primary dystonia identified additional THAP1 sequence variants in non-Amish subjects...
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4Y Tsuboi
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Neuropathol Appl Neurobiol 29:503-10. 2003....
Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity?C Wider
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Neurology 72:1953-9. 2009..This supports HDLS and POLD being referred collectively as adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP)...
Clinical genetics of Parkinson's disease and related disordersChristian Wider
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 13:S229-32. 2007..PRKN, PINK1 and DJ1 mutations cause early-onset recessively inherited PD. Autosomal dominant dementia and parkinsonism is caused by mutations in the MAPT gene, and in the most recently discovered PGRN gene...
Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlationChristian Wider
Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
Neurodegener Dis 7:175-9. 2010..Patients carrying an LRRK2 mutation display significant variability of clinical and pathologic phenotypes across and within affected families...
Progranulin gene mutation with an unusual clinical and neuropathologic presentationChristian Wider
Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA
Mov Disord 23:1168-73. 2008..This study further expands the clinical and pathological spectrum of PGRN mutations, and suggests the diagnosis could be missed in some individuals with atypical presentations...
Parkinson disease: handedness predicts asymmetryR J Uitti
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Neurology 64:1925-30. 2005..To determine the proportion of individuals in a clinic-based setting that present with asymmetric Parkinson disease (PD) and identify predictive factors associated with asymmetric symptoms...
Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutationT J Ferman
Department of Psychiatry and Psychology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 9:265-70. 2003..In addition, results suggest that letter fluency may be a sensitive predictor of incipient PPND...
Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonismZ K Wszolek
Mayo Clinic Jacksonville, Department of Neurology, Jacksonville, Florida 32224, USA
Acta Neuropathol (Berl) 103:344-50. 2002..Thus, the clinical and pathological findings in this family with autosomal dominant parkinsonism are similar to those of sporadic Parkinson's disease...
Clinical and genetic studies of families with the tau N279K mutation (FTDP-17)Y Tsuboi
Mayo Clinic, Jacksonville, FL 32224, USA
Neurology 59:1791-3. 2002..A founder effect indicated by a shared disease haplotype was seen only in two Japanese families. The N279K mutation can develop independently in different parts of the world...
Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroidsJ A Van Gerpen
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Neurology 71:925-9. 2008..To report a new American family with hereditary diffuse leukoencephalopathy with spheroids (HDLS), including serial, presymptomatic and symptomatic, cranial MRIs from the proband...
Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosisNicola J Rutherford
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America
PLoS Genet 4:e1000193. 2008....
Elucidating the genetics and pathology of Perry syndromeChristian Wider
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
J Neurol Sci 289:149-54. 2010..Further studies will examine reasons for the vulnerability of selected neuronal populations in Perry syndrome, and the link between the genetic defect and TDP-43 pathology...
[Japanese contribution to the understanding of frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)]Yoshio Tsuboi
Mayo Clinic Jacksonville, Department of Neurology, 4500 San Pablo Road, Jacksonville, Florida 32224, USA
No To Shinkei 55:107-19. 2003..It is hoped that future studies of these families will also lead to finding the curative treatments for the tauopathies...
Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremorBrett H Keeling
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 16:112-4. 2010....
Distinctive MRI findings in pallidopontonigral degeneration (PPND)Andrew R Frank
Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA
Neurology 68:620-1. 2007
Hereditary tauopathies and parkinsonismZbigniew K Wszolek
Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA
Adv Neurol 91:153-63. 2003
Progressive supranuclear palsy: phenotypic sex differences in a clinical cohortYasuhiko Baba
Department of Neurology, Mayo Clinic, Jacksonville, Florida 32224, USA
Mov Disord 21:689-92. 2006..In general, the disease phenotype was similar between men and women, suggesting that sex may have little or no influence on the development, expression, or progression of the PSP phenotype...
Genetic variants associated with myocardial infarction in the PSMA6 gene and Chr9p21 are also associated with ischaemic strokeM G Heckman
Biostatistics Unit, Mayo Clinic, Jacksonville, FL 32224, USA
Eur J Neurol 20:300-8. 2013..This study evaluated whether genetic risk factors for CAD and MI also affect susceptibility to ischaemic stroke in Caucasians and African Americans...
Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosisA J Whittle
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA
J Neural Transm 114:327-9. 2007..However we can not rule out other genetic variation at the LRRK2 locus may play a role in parkinsonian disorders with amyotrophic lateral sclerosis and may be considered candidates for genetic screening...
Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): PPND family. A longitudinal videotape demonstrationZ K Wszolek
Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA
Mov Disord 16:756-60. 2001....
Thalamic deep brain stimulation for tremor-predominant Parkinson's diseaseJ D Putzke
Department of Neurology, Davis Bldg E-8, Mayo Clinic Jacksonville, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 10:81-8. 2003..e. burning and tingling with stimulation). CONCLUSION: DBS is associated with stable tremor control in PD. Side-effects are typically easily managed with stimulation adjustments, although in some cases lead replacement may be required...
Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease)J R M Oliveira
Neurogenetics Program, Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1769, USA
Neurology 63:2165-7. 2004..The authors found evidence against linkage to IBGC1 in five of the six families supporting previous preliminary studies demonstrating genetic heterogeneity in familial IBGC...
Japanese family with parkinsonism, depression, weight loss, and central hypoventilationY Tsuboi
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Neurology 58:1025-30. 2002....
DCTN1 mutations in Perry syndromeMatthew J Farrer
Division of Neurogenetics, Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida 32224, USA
Nat Genet 41:163-5. 2009..Our findings show that DCTN1 mutations, previously associated with motor neuron disease, can underlie the selective vulnerability of other neuronal populations in distinct neurodegenerative disorders...
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expressionChristian Wider
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, USA
Mov Disord 24:455-9. 2009..We found no evidence of association between FGF20 variability and PD risk, and no relationship between the rs12720208 genotype, FGF20 and alpha-synuclein protein levels...
Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohortRyan J Uitti
Department of Neurology, Mayo Clinic Jacksonville, 4500 San Pablo Road, Cannaday Bldg E 2, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 11:139-45. 2005....
Fine-mapping and candidate gene investigation within the PARK10 locusKristoffer Haugarvoll
Department of Neuroscience and Neurology, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
Eur J Hum Genet 17:336-43. 2009..Our data indicate that genetic variability in USP24 is associated with PD. Although our work extends and confirms a previous report, the observed effect size does not explain the PARK10 linkage peak...
Genetic variation of Omi/HtrA2 and Parkinson's diseaseOwen A Ross
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida 32224, United States
Parkinsonism Relat Disord 14:539-43. 2008..Taken together our results do not support a role for Omi/HtrA2 variants in the pathogenesis of Parkinson's disease...
Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementiaRosa Rademakers
Department of Neuroscience, Mayo Clinic, Jacksonville, FL FL 32224, USA
Hum Mol Genet 17:3631-42. 2008..Translational regulation by miRNAs may represent a common mechanism underlying complex neurodegenerative disorders...
Dopamine beta-hydroxylase -1021C>T association and Parkinson's diseaseOwen A Ross
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 14:544-7. 2008..16, n=2696). We observed a modest association between DBH -1021C>T and AAO in the combined series (p=0.01). Taken together, these findings indicate that DBH -1021C>T does not play a major role in the pathogenesis of Parkinson's disease...
Body mass index is reduced early in Parkinson's diseaseWilliam P Cheshire
Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 11:35-8. 2005..These results suggest that alterations in nutrient intake or metabolism could reflect early changes in the central autonomic network preceding the emergence of classical extrapyramidal manifestations of PD...
DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson diseaseBrett H Keeling
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
Neurosci Lett 461:74-5. 2009..Statistical analysis failed to identify significant differences in the frequency of these variants between the case and control groups; therefore our results do not support a role for these DRD3 and HS1BP3 variants in PD...
Myoclonus in pallido-ponto-nigral degenerationJohn N Caviness
Department of Neurology, Mayo Clinic Scottsdale, Scottsdale, Arizona, USA
Adv Neurol 89:35-9. 2002
Physiologic assessment of autonomic dysfunction in pallidopontonigral degeneration with N279K mutation in the tau gene on chromosome 17William P Cheshire
Department of Neurology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA
Auton Neurosci 102:71-7. 2002..The degree of autonomic dysfunction correlated significantly with disease duration and with indices of disease severity. In conclusion, there is evidence in PPND of a disturbance in the central autonomic network...
Clinical-electrophysiological correlation of tremor and myoclonus in a kindred with the N279K tau mutationJohn N Caviness
Department of Neurology, Parkinson s Disease and Movement Disorders Center, Mayo Clinic Scottsdale, 13400 East Shea Boulevard, Scottsdale, AZ 85259, USA
Parkinsonism Relat Disord 9:151-7. 2003..Electrophysiology yielded remarkable findings in those asymptomatic at-risk individuals that carried the N279K tau mutation...
LRRK2 variation and Parkinson's disease in African AmericansOwen A Ross
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida 32224, USA
Mov Disord 25:1973-6. 2010..Given the ethnic-specific LRRK2 variation previously identified in PD further studies in under-represented populations are warranted...
Clinical implications of gene discovery in Parkinson's disease and parkinsonismChristian Wider
Department of Neurology, Mayo Clinic, Jacksonville, Florida 32224, USA
Mov Disord 25:S15-20. 2010..In addition, clinical treatment of PD remains largely unaltered by the results of genetic testing...
[Fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17): clinical criteria]Zbigniew K Wszolek
Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA
Neurol Neurochir Pol 37:173-84. 2003..Undoubtedly further research into the FTDP-17 will contribute to the development of a successful treatment for these devastating degenerative diseases of the c.n.s...
LINGO1 rs9652490 is associated with essential tremor and Parkinson diseaseCarles Vilariño-Güell
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 16:109-11. 2010..Our study demonstrates a significant association between LINGO1 rs9652490 and essential tremor (P = 0.014) and Parkinson disease (P = 0.0003), thus providing the first evidence of a genetic link between both diseases...
Is the neuropathological 'gold standard' diagnosis dead? Implications of clinicopathological findings in an autosomal dominant neurodegenerative disorderRyan J Uitti
Department of Neurology and the Section of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 10:461-3. 2004..We conclude that in certain circumstances genetic studies may provide definitive arbitration of validity of clinical and pathological diagnostic criteria...
GCH1 expression in human cerebellum from healthy individuals is not gender dependentChristian Wider
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA
Neurosci Lett 462:73-5. 2009....
Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindredBradley F Boeve
Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
Arch Neurol 63:268-72. 2006..There are no reports on the possible association of rapid eye movement sleep without atonia and RBD with any familial tauopathy...
Essential tremor: phenotypic expression in a clinical cohortN R Whaley
Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32225, USA
Parkinsonism Relat Disord 13:333-9. 2007..Examine the characteristics of an essential tremor (ET) clinical cohort including base-rate variability of several commonly accepted diagnostic criteria...
ELAVL4, PARK10, and the CeltsKristoffer Haugarvoll
Department of Neuroscience and Neurology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA
Mov Disord 22:585-7. 2007..Our data suggest that the association between ELAVL4 and PD previously observed might be explained by a Celtic-founder effect...
Effect of MAPT and APOE on prognosis of progressive supranuclear palsyYasuhiko Baba
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Neurosci Lett 405:116-9. 2006..These results support the assertion that the H1/H1 genotype may contribute to the earlier occurrence of clinical symptoms...
Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's diseaseOwen A Ross
Department of Neuroscience, Molecular Genetics Laboratory and Core, Morris K Udall Parkinson s Disease Research Center of Excellence, Mayo Clinic, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 13:386-8. 2007..These data do not support a role for this common variant in PD etiology...
Rapidly progressive familial parkinsonism with central hypoventilation, depression and weight loss (Perry syndrome)--a literature reviewChristian Wider
Department of Neurology, Mayo Clinic College of Medicine, Cannaday Building 2E, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Parkinsonism Relat Disord 14:1-7. 2008..Neuropathology shows severe neuronal loss in the substantia nigra, less prominent neuronal loss in the locus coeruleus, and no or few Lewy bodies. In this review, we also propose diagnostic criteria for this condition...
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's diseaseJulie P Taylor
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
Neurogenetics 8:95-102. 2007..Comparison of evolutionary interspecies sequences of LRRK1 and LRRK2 suggests they diverged from a common founder gene...
Pharmacologic management of seizures in organ transplantDavid R Chabolla
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Neurology 67:S34-8. 2006..Other, newer agents are not subject to this interaction, and further studies are needed to define their role in the management of seizures in transplant patients...
A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body diseaseH L Melrose
Molecular Genetics Laboratory and Core, Morris K Udall Parkinson s Disease Research Center of Excellence, Mayo Clinic, Department of Neuroscience, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Neuroscience 147:1047-58. 2007..A role for Lrrk2 in neurogenesis might provide further insight into the aberrant role of mutant protein in age-associated neurodegeneration with pleomorphic pathology...
Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5C Wider
Department of Neurology, Cannaday Building 2E, Mayo Clinic, San Pablo Road 4500, Jacksonville, FL 32246, USA
Neurology 70:1377-83. 2008..To report the study of a multigenerational Swiss family with dopa-responsive dystonia (DRD)...
Medications used to treat Parkinson's disease and the risk of gamblingA Imamura
Department of Neurology, Mayo Clinic, Jacksonville, FL, USA
Eur J Neurol 15:350-4. 2008..9). Patients with PD who newly developed gambling behavior were more likely to have been taking Pramipexole than other anti-PD medication. However, the association between Pramipexole and gambling behavior is not necessarily etiologic...
Depression in Parkinson's diseaseBarbara Jasinska-Myga
Department of Neurology, Mayo Clinic, Jacksonville, Florida 32224, USA
Can J Neurol Sci 37:61-6. 2010..To examine predictive factors associated with onset of depression among individuals diagnosed with Parkinson's disease (PD)...
Parkinsonism, FXTAS, and FMR1 premutationsMathias Toft
Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA
Mov Disord 20:230-3. 2005..Five patients (1.2%) carry intermediate-size alleles (41-54 CGG repeats). Expansions within the FMR1 gene are not associated with PD in our study...
Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French familyYoshio Tsuboi
Department of Neurology, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA
Arch Neurol 59:943-50. 2002..Results of genealogical and molecular genetic studies determined that the families were not related. The N279K mutations found in both families have independent origins...
Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphismsStacey Melquist
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
Am J Hum Genet 80:769-78. 2007..Since DNA damage and lysosomal dysfunction have been implicated in aging and neurodegenerative processes, both genes are viable candidates for conferring risk of disease...
De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosisMariely DeJesus-Hernandez
Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Hum Mutat 31:E1377-89. 2010..S402_P411delinsGGGG) which is predicted to expand a conserved poly-glycine motif. Our findings extend the mutation spectrum in FUS leading to ALS and describe the first de novo mutation in FUS...
Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body diseaseKenya Nishioka
Department of Neuroscience, Mayo Clinic Florida, 4500 San Pablo Rd, Jacksonville, FL 32224, USA
Arch Neurol 67:970-5. 2010..To determine the association of the genes that encode alpha-, beta-, and gamma-synuclein (SNCA, SNCB, and SNCG, respectively) with diffuse Lewy body disease (DLBD)...
The genetics of frontotemporal dementiaKristoffer Haugarvoll
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL 32224, USA
Neurol Clin 25:697-715, vi. 2007..The clinical and neuropathologic features of frontotemporal dementia with parkinsonism linked to chromosome 17 and the nature of the mutations in the progranulin and microtubule-associated protein tau genes are emphasized...
The human sideroflexin 5 (SFXN5) gene: sequence, expression analysis and exclusion as a candidate for PARK3Paul J Lockhart
Mayo Clinic Jacksonville, Birdsall Building, 4500 San Pablo Road, Jacksonville, FL 32224, USA
Gene 285:229-37. 2002..Sequence analysis of 2p13 linked individuals affected with PD did not reveal any potentially pathogenic mutations within SFXN5, suggesting SFXN5 does not correspond to PARK3...
Lrrk2 pathogenic substitutions in Parkinson's diseaseIgnacio F Mata
Department of Neurology, Mayo Clinic, Jacksonville, FL 32224, USA
Neurogenetics 6:171-7. 2005..Seven of these coding changes seem to be pathogenic, as they segregate with disease and were not identified within controls. No multiplications or deletions were identified...
MR imaging of brainstem atrophy in progressive supranuclear palsyJerzy Slowinski
Department of Neurology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, United States
J Neurol 255:37-44. 2008..To enhance the sensitivity and specificity of the clinical diagnosis of progressive supranuclear palsy (PSP), neuroradiological parameters established in pathologically proven cases are needed...
